ZBH
Zimmer Biomet Holdings, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +17.6% ·
share flow +0.3% ·
net new positions +15.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +1 | 160.27M | $13.80B | +8 | −6 |
| Q1 2026 | 159 | -2 | 157.26M | $14.21B | +8 | −11 |
| Q4 2025 | 160 | -1 | 174.74M | $15.72B | +3 | −3 |
| Q3 2025 | 25 | +3 | 107.43M | $10.58B | +3 | −1 |
| Q2 2025 | 20 | -3 | 103.64M | $9.45B | +2 | −5 |
| Q1 2025 | 20 | +3 | 59.00M | $6.68B | +3 | — |
| Q4 2024 | 17 | 0 | 58.85M | $6.22B | +1 | −1 |
| Q3 2024 | 16 | -2 | 46.04M | $4.97B | — | −2 |
| Q2 2024 | 18 | — | 44.34M | $4.81B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 19.56M | +2.3% | $2.21B | 1.3% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 14.46M | -2.1% | $1.64B | 0.2% | ▼ Trim | 4 | SEC ↗ ×2 |
| 3 | State Street Global Advisors ✦ (passive) | 8.75M | -2.5% | $992.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 5.06M | +3.6% | $570.36M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | PRIMECAP Management ✦ | 4.68M | -2.4% | $530.02M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 2.13M | +3.9% | $240.68M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 2.04M | -15.1% | $231.18M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 8 | Millennium Management ✦ | 676.11K | +378.4% | $76.52M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 472.72K | +2.8% | $53.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Marshall Wace ✦ | 347.85K | New | $39.37M | 0.1% | New | 1 | SEC ↗ ×3 |
| 11 | AQR Capital Management ✦ | 345.31K | -18.3% | $38.76M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 12 | GAMCO Investors ✦ | 200.79K | -3.6% | $22.73M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 87.83K | New | $9.94M | 0.0% | New | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 46.23K | -85.4% | $5.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 37.24K | New | $4.21M | 0.0% | New | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 36.87K | +230.6% | $4.17M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 17 | Two Sigma Investments ✦ | 30.40K | -21.4% | $3.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 22.14K | -56.4% | $2.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 8.52K | -95.8% | $964,407 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 4.57K | -12.9% | $517,256 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $39.37M | 0.1% |
| Point72 Asset Management | $9.94M | 0.0% |
| Adage Capital Partners | $4.21M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 908 holders, 191.49M shares, $15.84B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 5.69K sh · $528,978
Officer · 3.00K sh · $295,050
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology